Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 USD | -0.16% | 0.00% | +14.29% |
Mar. 13 | Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share | MT |
Mar. 13 | Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023. | CI |
Performance
1 day | -0.16% | ||
Current month | -0.16% | ||
1 month | -0.16% | ||
3 months | -16.88% | ||
6 months | -30.43% | ||
Current year | +14.29% | ||
1 year | -35.56% | ||
3 years | -54.12% | ||
5 years | -43.04% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.16% | 0.00% | +14.29% | -35.56% | 6.12M | ||
+1.19% | +0.99% | +25.83% | +87.91% | 661B | ||
+2.28% | +2.36% | +27.00% | +58.78% | 566B | ||
-0.46% | -1.20% | -6.76% | -10.34% | 352B | ||
+0.37% | +4.31% | +20.34% | +13.93% | 332B | ||
-4.58% | -4.08% | +3.00% | +7.22% | 283B | ||
-0.32% | +9.52% | +13.09% | +1.63% | 231B | ||
-0.56% | +4.64% | +5.46% | -2.03% | 200B | ||
+1.01% | -0.50% | -9.61% | -19.99% | 195B | ||
+0.22% | +0.39% | -6.26% | +12.33% | 145B | ||
+0.55% | -2.31% | -11.77% | -34.43% | 144B | ||
-0.43% | +4.99% | +1.64% | -10.40% | 122B | ||
+0.34% | -8.34% | -12.59% | -33.66% | 90.92B | ||
+0.76% | +3.38% | +13.98% | +15.03% | 84.13B | ||
+0.23% | -2.01% | -19.24% | -21.70% | 81.58B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | +0.03% | +0.92% | +3.89% | +1.91% | ||
Weighted average by Cap. | +0.26% | +1.32% | +10.29% | +23.65% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +14.29% | ||
2023 | -41.72% | ||
2022 | -5.37% | ||
2021 | -6.76% | ||
2020 | -27.05% | ||
2019 | +105.87% | ||
2018 | -16.63% | ||
2017 | -50.35% | ||
2016 | -24.66% |
- Stock Market
- Equities
- CTX Stock
- CRRTF Stock
- Quotes Crescita Therapeutics Inc.